Event Detail (Archived)

From a Single Patient to a U.S. FDA Approved Drug: The Story of a Drug Repositioning for a Rare Disease

  • This event already took place in January 2025
  • Carson Family Auditorium (CRC)

Event Details

Type
Seminars in Clinical Research
Speaker(s)
Guillaume Canaud, M.D., Ph.D., professor and principal investigator, unité de médecine translationnelle et thérapies ciblées, Hôpital Necker-Enfants Malades, Université Paris Cité
Open to
Tri-Institutional

Related News

This new, one-two punch could knock out drug-resistant TB

Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.

Hess Center for Research on Women’s Health and Biomedicine holds its inaugural symposium

Covering topics from osteoarthritis to neurodevelopment, the inaugural symposium of the Marlene Hess Center showcased research that illuminates how biological sex shapes health and disease.

A new reference brain could make the clonal raider ant a go-to model species for neuroscience  

Researchers created this first-of-its kind map by merging 40 ant brains into one.

Related Events

Brain Dynamics

| CARSON FAMILY AUDITORIUM (CRC)

Pre-Seminar Coffee and Cookies

| LOWER LEVEL GREENBERG BUILDING (CRC)

Some Observations on How AlphaFold Predicts, and Learns to Predict, Protein Structures.

| CARSON FAMILY AUDITORIUM (CRC)